Pharmaceutical / Drug Definition :
Blocks stimulation of beta1-adrenergic (myocardial) and beta2-adrenergic (pulmonary, vascular, and uterine) receptor sites. This action decreases cardiac output, slows heart rate, and reduces blood pressure.
FDA Label Requirements and Exceptions
Propranolol Hydrochloride
FDA Import Information
Propranolol Hydrochloride
FDA Detentions
Propranolol Hydrochloride (Propranolol Hydrochloride Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Propranolol Hydrochloride (Propranolol Hydrochloride Suppliers)
- Processors Propranolol Hydrochloride
- Repackers Propranolol Hydrochloride
- Relabelers Propranolol Hydrochloride
- Exporters Propranolol Hydrochloride
- Importers Propranolol Hydrochloride
For more information about Propranolol Hydrochloride, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.